Cargando…
The function of LncRNA-H19 in cardiac hypertrophy
Cardiac hypertrophy, characterized by the enlargement of cardiomyocytes, is initially an adaptive response to physiological and pathological stimuli. Decompensated cardiac hypertrophy is related to fibrosis, inflammatory cytokine, maladaptive remodeling, and heart failure. Although pathological myoc...
Autores principales: | Su, Wenhua, Huo, Qian, Wu, Hao, Wang, Lulin, Ding, Xiaoxue, Liang, Liwen, Zhou, Liang, Zhao, Yan, Dan, Juhua, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336097/ https://www.ncbi.nlm.nih.gov/pubmed/34344446 http://dx.doi.org/10.1186/s13578-021-00668-4 |
Ejemplares similares
-
How does NFAT3 regulate the occurrence of cardiac hypertrophy?
por: Hui, Wang, et al.
Publicado: (2023) -
Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy
por: Song, Chao, et al.
Publicado: (2016) -
The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214
por: Lv, Lifang, et al.
Publicado: (2017) -
LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
por: Shao, Mingjing, et al.
Publicado: (2017) -
lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy
por: Neppl, Ronald L, et al.
Publicado: (2017)